IDEAYA Biosciences, Inc. (IDYA)

NASDAQ: IDYA · Real-Time Price · USD

33.19

+0.16 (0.48%)

At close: Mar 6, 2026, 4:00 PM EST

33.85

+0.66 (1.99%)

After-hours: Mar 6, 2026, 7:36 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Research and Development for Oncology-Focused Precision Medicine	218.71M	7.00M	23.39M	50.93M	27.94M
Research and Development for Oncology-Focused Precision Medicine Growth	3024.43%	-70.07%	-54.08%	82.28%	43.01%
Total	218.71M	7.00M	23.39M	50.93M	27.94M
Total Growth	3024.43%	-70.07%	-54.08%	82.28%	43.01%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	218.71M	7.00M	23.39M	50.93M	27.94M
United States Growth	3024.43%	-70.07%	-54.08%	82.28%	43.01%
Total	218.71M	7.00M	23.39M	50.93M	27.94M
Total Growth	3024.43%	-70.07%	-54.08%	82.28%	43.01%

Source: S&P Global Market Intelligence.